课题基金 / 基金详情

Nanomagnetic Molecular Materials

Nanomagnetic Molecular Materials
纳米磁性分子材料
批准号:
DP0877255
负责人:
Em/Prof Keith Murray
金额:
$39.71万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-04-01 至 2010-12-31

项目摘要

项目成果

Em/Prof Keith Murray的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This research project involves the preparation of new molecular magnets using metals such as manganese and vanadium and a study of their physical properties. Metal compounds of the cluster type are significant since they are nanoscale in size and offer new quantum features, with an improved understanding of the magnetic properties as a primary outcome and long term possible use in future quantum computers. This fundamental study provides excellent training to post-graduate students and makes them ideally suited to take jobs in advanced materials, an area being emphasised in Australia's nanotechnological future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular magnetic materials of the cluster and network types
  • 批准号:
    DP110100525
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.56万
  • 财政年份:
    2011
  • 负责人:
    Em/Prof Keith Murray
  • 依托单位:
National magnetochemical facility
  • 批准号:
    LE100100197
  • 项目类别:
    Linkage Infrastructure, Equipment and Facilities
  • 资助金额:
    $13.34万
  • 财政年份:
    2010
  • 负责人:
    Em/Prof Keith Murray
  • 依托单位:
Nanomagnetic Materials from Molecular Clusters and Coordination Polymers
  • 批准号:
    DP0342593
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $36.66万
  • 财政年份:
    2003
  • 负责人:
    Em/Prof Keith Murray
  • 依托单位:
Cooperativity in Spin-Crossover Systems: Memory, Magnetism and Microporosity
  • 批准号:
    DP0209486
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $23.46万
  • 财政年份:
    2002
  • 负责人:
    Em/Prof Keith Murray
  • 依托单位:
国内基金
海外基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
Molecular Plant
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
Molecular Plant